An analysis of the effects of smoking and other cardiovascular risk factors on obliteration rates after arteriovenous malformation radiosurgery

被引:13
作者
Bhatnagar, A
Flickinger, JC
Kondziolka, D
Niranjan, A
Lunsford, LD
机构
[1] Univ Pittsburgh, Sch Med, Ctr Image Guided Neurosurg, Dept Radiol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Pittsburgh, PA 15213 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 51卷 / 04期
关键词
arteriovenous malformation; radiosurgery; cardiovascular risk factors; smoking;
D O I
10.1016/S0360-3016(01)01734-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess the relationships of smoking and other cardiovascular disease risk factors (hypertension, diabetes, hypercholesterolemia, and gender) to rates of radiosurgery-induced obliteration of arteriovenous malformations (AVM). Methods and Materials: We evaluated follow-up imaging and clinical data in 329 AVM patients who received gamma knife radiosurgery at the University of Pittsburgh between 1987 and 1994. There were 113 smokers, 29 hypertensives, 5 diabetics, 4 hypercholesterolemics, 159 male patients, and 170 female patients. All patients had regular clinical or imaging follow-up for a minimum of 3 years after radiosurgery. Results: Multivariate analysis showed that smoking had no effect on AVM obliteration (p > 0.43). Hypertension, diabetes, and hypercholesterolemia had no discernible effect on AVM obliteration in this study (p > 0.78). However, females aged 12-49 had a statistically significant lower in-field obliteration rate than males (78% vs. 89%,p = 0.0102). Conclusion: Smoking has no effect on AVM obliteration. Hypertension, diabetes, and hypercholesterolemia had no discernible effect in this study. Further study is needed to establish whether estrogen has a vascular protective effect that could partially limit radiosurgical AVM obliteration, as suggested by this study. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 25 条
[1]  
Chang SD, 1997, CLIN NEUROPATHOL, V16, P111
[2]  
COLOMBO F, 1994, NEUROSURGERY, V34, P14
[3]   Analysis of treatment failure after radiosurgery for arteriovenous malformations [J].
Ellis, TL ;
Friedman, WA ;
Bova, FJ ;
Kubilis, PS ;
Buatti, JM .
JOURNAL OF NEUROSURGERY, 1998, 89 (01) :104-110
[4]  
Flickinger J. C., 2000, International Journal of Radiation Oncology Biology Physics, V48, P255, DOI 10.1016/S0360-3016(00)80308-9
[5]   A dose-response analysis of arteriovenous malformation obliteration after radiosurgery [J].
Flickinger, JC ;
Pollock, BE ;
Kondziolka, D ;
Lunsford, LD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (04) :873-879
[6]   LINEAR-ACCELERATOR RADIOSURGERY FOR ARTERIOVENOUS-MALFORMATIONS - THE RELATIONSHIP OF SIZE TO OUTCOME [J].
FRIEDMAN, WA ;
BOVA, FJ ;
MENDENHALL, WM .
JOURNAL OF NEUROSURGERY, 1995, 82 (02) :180-189
[7]   Treatment of brain arteriovenous malformations by embolization and radiosurgery [J].
Gobin, YP ;
Laurent, A ;
Merienne, L ;
Schlienger, M ;
Aymard, A ;
Houdart, E ;
Casasco, A ;
Lefkopoulos, D ;
George, B ;
Merla, JJ .
JOURNAL OF NEUROSURGERY, 1996, 85 (01) :19-28
[8]   Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland [J].
Hart, CL ;
Hole, DJ ;
Smith, GD .
STROKE, 1999, 30 (10) :1999-2007
[10]   Can the probability for obliteration after radiosurgery for arteriovenous malformations be accurately predicted? [J].
Karlsson, B ;
Lax, I ;
Söderman, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (02) :313-319